Sandoz has announced the launch of a new generic antidepressant in a number of European countries.
The company has commenced the EU rollout of generic escitalopram - an affordable and high-quality version of the branded reference product Cipralex - in Belgium, France, Germany, Italy, Sweden and Switzerland.
“Sandoz has launched generic escitalopram, an affordable version of the branded antidepressant Cipralex, in several European nations.“
It is available in all strengths approved for the original product - 5 mg, 10 mg, 15 mg and 20 mg - and will allow Sandoz to tap into a market valued at around $600 million (358.22 million pounds), according to IMS sales estimates for Cipralex.
Nick Haggar, head of Sandoz in western Europe, the Middle East and Africa, said: "Sandoz is already a regional leader in the segment of generic central nervous system therapies. This launch further strengthens that position and drives access to affordable high-quality versions of critical medicines."
This comes after the firm introduced Mometasone Sandoz, the first generic version of leading respiratory therapy Nasonex, in France last week.See all the latest jobs in Consumer